Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
FAIRification – don’t overthink it, just do it and tell others how
Posted on March 4th, 2020 by Ted Slater in Pharma R&D
Ideas change the world, but rarely without a lot of missteps, rethinking and redoing. The FAIR Data Principles are no exception: mostly, they emerged from ideas that were developed over the course of years before being consolidated and named in 2016, and now we’re in the thick of trying, learning, maturing.
Just how far we’ve come in implementing the FAIR Principles was the underlying theme of a forum hosted by FAIRplus this January. People with the deepest understanding and experience of FAIR shared lessons learned and visions for the future.
Members of the FAIRplus project – a consortium developing tools and guidelines to make life science data FAIR – presented their achievements so far. Among other initiatives, small-medium enterprises are receiving FAIR Data training and the FAIR Cookbook is collecting standardized ‘recipes’ to FAIRify different types of life science data.
Other participants surveyed the landscape of FAIR Data in businesses, from their value and use to the need for deeper automation and scale-up. Lastly, discussion panels highlighted insights from businesses offering FAIRification services and the priorities of initiatives driving the adoption of the FAIR Principles.
Exciting urgency was the undertone throughout talks and discussions. ‘Excitement’ because processes for data FAIRification are maturing rapidly. A remarkable ecosystem of projects, businesses, initiatives and services has emerged from what Carole Goble called in her Keynote speech “the rallying call” ignited in 2016. Today, with proper stewardship of data, FAIRification can be done at scale with the help of best practices, expertise, technologies and tools.
Tony Burdett from EMBL-EBI explained how the FAIRplus FAIRification Process was implemented on datasets from four IMI and EFPIA projects. Those datasets are available in the Translational Medicine Data Catalogue and have been assessed according to FAIR indicators and the resulting FAIR recipes are included in the FAIR Cookbook. The pieces of a robust FAIR framework are coming together.
The ‘urgency’ was at the same time a warning against thinking that a FAIR pinnacle must be achieved, and encouragement to start FAIRification now – however large or small the undertaking. Data are not either FAIR or not FAIR. Rather, FAIRness is a spectrum and your data can be more or less FAIR depending upon their intended uses. Paraphrasing Carole Goble’s “practice by FAIR mortals”: decide how FAIR your data need to be, get skills in your team and expert help from the community, publish your data and document what you do so others can learn.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
- Infographic: Elsevier’s Professional Services team provides COVID-19 insights
- Webinar: Accelerating drug discovery by building and turning high-quality data into actionable insights
- Personal Health Train initiative gives researchers data access FAIRly
- Bridging information silos the FAIR way
- How can we get pharma R&D to embrace FAIR data?